Data on Rafael Pharmaceuticals’ CPI-613® (devimistat) in Patients with Relapsed Burkitt Lymphoma to be Presented at the 2019 American Society of Hematology (ASH) Annual Meeting & Exposition

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement